Definition of allogeneic B7.1/HLA-A1 transfected tumor cell vaccine - National Cancer Institute Drug Dictionary

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Search for

Starts with

Contains

All

allogeneic B7.1/HLA-A1 transfected tumor cell vaccine
An allogeneic whole cell vaccine, derived from irradiated allogenic tumor cells manipulated to express human B7.1 (CD80 antigen) and human leukocyte antigen (HLA) A1, with potential antitumor activity. Vaccination with allogeneic B7.1/HLA-A1 transfected tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor cell proliferation. Check for or using this agent. ()

Previous:	Alferon N, alfuzosin hydrochloride, ALIMTA, alitretinoin, Alkeran
Next:	allogeneic CD4+ memory Th1-like T cells/microparticle-bound anti-CD3/anti-CD28, allogeneic dendritic cell-myeloma idiotype vaccine, allogeneic GM-CSF-secreting breast cancer vaccine, allogeneic tumor cell vaccine, allopurinol